Live Breaking News & Updates on Global Huntington Disease Population Stratified

Stay updated with breaking news from Global huntington disease population stratified. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Teva to Present New Data on Once-Daily AUSTEDO® XR (deutetrabenazine) Extended-Release Tablets at the 2023 American Academy of Neurology Annual Meeting

Dose proportionality and bioequivalence studies demonstrate once-daily AUSTEDO XR is therapeutically equivalent to twice-daily AUSTEDO® tablets

The U.S. Food and Drug Administration . | April 11, 2023 ....

United States , Eric Hughes , Teva Pharmaceuticals , Teva Pharmaceutical Industries Ltd , Drug Administration , American Academy Of Neurology , Teva Pharmaceutical Industries , American Academy , Annual Meeting , Executive Vice President , Chief Medical Officer , Chorea Severity Change Over Time , Huntington Disease , Huntington Disease Stage , Sunday April , Bioequivalence Comparison , Steady State , Approved Twice Daily Tablet Formulation , Dose Proportionality , Three Dose Strengths , Clinical Dose Range , Real World Effectiveness , Antipsychotic Drugs , Baseline Characteristics , Treatment Patterns , Global Huntington Disease Population Stratified ,